For example, the upregulation of FOXD3-AS1 enhances the development of NSCLC [24], whereas inhibition of FOXD3-AS1 restrains the aggressiveness of thyroid cancer cells through inactivation of the TGF-β1/Smads pathway [25]. This evidence concerns the gene TGFB1 and thyroid gland carcinoma.